Skip to main content

Table 3 Description of the population by univariate logistic regression test using the pathological data

From: A model building exercise of mortality risk for Taiwanese women with breast cancer

  Pathological Data
Risk factors Mortality(%) Odds Ratio P-value
Pathological report   <.001 (a v.s. c) N.S.
   0.532 (b v.s. c) N.S.
   Others (a) (n = 138) 0   
   Invasive ductal carcinoma (b) (n = 966) 66 (6.8%)   
   Invasive lobular carcinoma (c) (n = 33) 4 (12.1%)   
Tumor grade   2.172 <.0001 *
   III (n = 234) 27 (11.5%)   
   II (n = 431) 24 (5.6%)   
   I (n = 294) 8 (2.7%)   
ER/PR   1.99 0.009 *
   (-, -), (-, +), (+, -) (n = 583) 47 (8.1%)   
   (+, +) (n = 545) 23 (4.2%)   
Her-2/Neu   2.125 0.014*
   +++ (n = 181) 18 (9.9%)   
   -, +, ++ (n = 668) 33 (4.9%)   
EIC   2.036 0.032 *
   Absent (n = 590) 46 (7.8%)   
   Present (n = 301) 12 (4.0%)   
LTE   2.856 0.0004 *
   Present (n = 501) 46 (9.2%)   
   Absent (n = 468) 16 (3.4%)   
HBsAg   1.22 N.S.
   + (n = 124) 8 (6.5%)   
   - (n = 598) 32 (5.4%)   
HCVAb   1.103 N.S.
   + (n = 50) 3 (6%)   
   - (n = 658) 36 (5.5%)   
R/T   1.002 N.S.
   Yes (n = 581) 39 (6.7%)   
   No (n = 552) 31 (5.6%)   
Anti-hormone therapy   1.002 N.S.
   No (n = 228) 14 (6.2%)   
   Yes (n = 909) 56 (6.2%)   
Tumor size   2.579 <.0001 *
   T4 (n = 57) 10 (17.5%)   
   T2 or T3 (n = 595) 45 (7.6%)   
   Tis or T1 (n = 485) 15 (3.1%)   
Node   4.053 <.0001 *
   N3 (n = 81) 23 (28.4%)   
   N1 or N2 (n = 377) 31 (8.2%)   
   N0 (n = 677) 16 (2.4%)   
Chemotherapy   0.061 (a v.s. c) <0.0001*
   0.391 (b v.s. c) 0.009 *
   No (a) (n = 327) 4 (1.2%)   
   Yes (b) (n = 745) 55 (7.4%)   
   Abandonment or Refusal (c) (n = 65) 11 (18%)   
  1. N. S.: Statistically not significant
\